New CEO Tobin, Three Approvals Signal Smoother Times For Boston Scientific
This article was originally published in The Gray Sheet
Executive SummaryBoston Scientific used the opportunity of its annual March meeting with analysts to announce the selection of James Tobin as the next CEO, a move aimed at allaying the financial community's ongoing concerns about the firm's management and direction.
You may also be interested in...
Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.